Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 22 studies | 66% ± 20% | |
lung | 19 studies | 65% ± 21% | |
intestine | 13 studies | 62% ± 24% | |
brain | 12 studies | 34% ± 15% | |
eye | 10 studies | 51% ± 26% | |
kidney | 9 studies | 57% ± 19% | |
lymph node | 7 studies | 76% ± 13% | |
liver | 7 studies | 55% ± 27% | |
bone marrow | 6 studies | 58% ± 24% | |
uterus | 6 studies | 65% ± 29% | |
pancreas | 5 studies | 70% ± 30% | |
placenta | 4 studies | 69% ± 29% | |
breast | 4 studies | 79% ± 8% | |
ovary | 3 studies | 58% ± 26% | |
heart | 3 studies | 34% ± 17% | |
adipose | 3 studies | 38% ± 25% | |
adrenal gland | 3 studies | 57% ± 26% | |
esophagus | 3 studies | 62% ± 30% | |
thymus | 3 studies | 70% ± 32% | |
prostate | 3 studies | 89% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 18580.65 | 180 / 180 | 100% | 801.36 | 430 / 430 |
stomach | 100% | 20220.70 | 359 / 359 | 100% | 533.84 | 286 / 286 |
esophagus | 100% | 28099.01 | 1443 / 1445 | 100% | 492.79 | 183 / 183 |
intestine | 100% | 30106.75 | 966 / 966 | 100% | 536.84 | 526 / 527 |
uterus | 100% | 23179.81 | 170 / 170 | 100% | 607.99 | 458 / 459 |
skin | 100% | 28071.76 | 1808 / 1809 | 100% | 620.35 | 471 / 472 |
lung | 100% | 25411.76 | 577 / 578 | 100% | 459.77 | 1153 / 1155 |
bladder | 100% | 31646.43 | 21 / 21 | 100% | 509.56 | 502 / 504 |
thymus | 100% | 19099.35 | 652 / 653 | 99% | 313.27 | 601 / 605 |
breast | 100% | 25224.61 | 459 / 459 | 99% | 347.96 | 1107 / 1118 |
prostate | 100% | 20250.78 | 244 / 245 | 99% | 305.81 | 497 / 502 |
kidney | 100% | 17299.25 | 89 / 89 | 96% | 284.89 | 868 / 901 |
pancreas | 92% | 8974.34 | 301 / 328 | 100% | 334.15 | 178 / 178 |
brain | 85% | 7053.43 | 2234 / 2642 | 99% | 431.20 | 699 / 705 |
liver | 85% | 8840.16 | 192 / 226 | 98% | 235.29 | 398 / 406 |
adrenal gland | 100% | 15053.18 | 258 / 258 | 70% | 128.48 | 162 / 230 |
adipose | 100% | 30614.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 33342.39 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 658.78 | 29 / 29 |
muscle | 100% | 54153.04 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 18980.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 514.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 158.77 | 1 / 1 |
peripheral blood | 99% | 26759.76 | 920 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 431.56 | 79 / 80 |
heart | 98% | 29693.17 | 847 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0010468 | Biological process | regulation of gene expression |
GO_2000767 | Biological process | positive regulation of cytoplasmic translation |
GO_0050658 | Biological process | RNA transport |
GO_0008544 | Biological process | epidermis development |
GO_0006397 | Biological process | mRNA processing |
GO_1990428 | Biological process | miRNA transport |
GO_0001701 | Biological process | in utero embryonic development |
GO_0098761 | Biological process | cellular response to interleukin-7 |
GO_1903608 | Biological process | protein localization to cytoplasmic stress granule |
GO_2000773 | Biological process | negative regulation of cellular senescence |
GO_0048255 | Biological process | mRNA stabilization |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0008380 | Biological process | RNA splicing |
GO_0048598 | Biological process | embryonic morphogenesis |
GO_0070934 | Biological process | CRD-mediated mRNA stabilization |
GO_0051154 | Biological process | negative regulation of striated muscle cell differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_1900152 | Biological process | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_0051031 | Biological process | tRNA transport |
GO_0017148 | Biological process | negative regulation of translation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005689 | Cellular component | U12-type spliceosomal complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000932 | Cellular component | P-body |
GO_0071204 | Cellular component | histone pre-mRNA 3'end processing complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0070937 | Cellular component | CRD-mediated mRNA stability complex |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0062153 | Molecular function | C5-methylcytidine-containing RNA reader activity |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0051020 | Molecular function | GTPase binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0035198 | Molecular function | miRNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | YBX1 |
Protein name | Y-box-binding protein 1 (Y-box transcription factor) YBX1 protein Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor) |
Synonyms | YB1 NSEP1 |
Description | FUNCTION: DNA- and RNA-binding protein involved in various processes, such as translational repression, RNA stabilization, mRNA splicing, DNA repair and transcription regulation . Predominantly acts as a RNA-binding protein: binds preferentially to the 5'-[CU]CUGCG-3' RNA motif and specifically recognizes mRNA transcripts modified by C5-methylcytosine (m5C) . Promotes mRNA stabilization: acts by binding to m5C-containing mRNAs and recruiting the mRNA stability maintainer ELAVL1, thereby preventing mRNA decay . Component of the CRD-mediated complex that promotes MYC mRNA stability . Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors (By similarity). Plays a key role in RNA composition of extracellular exosomes by defining the sorting of small non-coding RNAs, such as tRNAs, Y RNAs, Vault RNAs and miRNAs . Probably sorts RNAs in exosomes by recognizing and binding C5-methylcytosine (m5C)-containing RNAs . Acts as a key effector of epidermal progenitors by preventing epidermal progenitor senescence: acts by regulating the translation of a senescence-associated subset of cytokine mRNAs, possibly by binding to m5C-containing mRNAs . Also involved in pre-mRNA alternative splicing regulation: binds to splice sites in pre-mRNA and regulates splice site selection . Binds to TSC22D1 transcripts, thereby inhibiting their translation and negatively regulating TGF-beta-mediated transcription of COL1A2 (By similarity). Also able to bind DNA: regulates transcription of the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7' . Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes . Promotes separation of DNA strands that contain mismatches or are modified by cisplatin . Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA, suggesting a role in DNA repair . The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation . . |
Accessions | ENST00000321358.12 Q6PKI6 ENST00000332220.10 P67809 C9J5V9 A0JLU4 H0Y449 ENST00000436427.1 |